ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0569

Cytokine Storm Susceptibility Factors IL-18 and Cytotoxic Impairment Converge on Pathologic CD8 T-cell Hyperactivation

Emily Landy1, Scott Canna2, Paul Tsoukas3, Vinh Dang2 and Jemy Varghese2, 1University of Pittsburgh, Pittsburgh, PA, 2Children's Hospital of Philadelphia, Philadelphia, PA, 3The Hospital for Sick Children, Toronto, ON, Canada

Meeting: ACR Convergence 2022

Keywords: cytokines, Cytotoxic Cells, Inflammation, macrophage activation syndrome, T Cell

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2022

Title: Abstracts: Pediatric Rheumatology – Basic Science

Session Type: Abstract Session

Session Time: 8:00AM-9:00AM

Background/Purpose: Mounting evidence suggests partial defects in cytotoxicity-related genes may promote hyperinflammation in Macrophage Activation Syndrome (MAS) patients, who uniformly have highly-elevated IL-18. In mice, neither excess IL-18 (18tg mice) nor perforin-deficiency individually cause immunopathology without inflammatory challenge. However,18tg mice lacking perforin (18tg;Prf1-/-) develop spontaneous lethal hyperinflammation, while subclinical MAS was found in 18tg;Prf1+/- mice. Recent studies in both HLH and MAS patients demonstrate CD8 T-cell activation profiles in peripheral blood. We sought to understand how these two susceptibility factors, IL-18 and cytotoxic impairment, synergize or converge on CD8 T cells to drive spontaneous hyperinflammation.

Methods: We bred and examined transgenic mice bearing single susceptibility and dual susceptibility factors to hyperinflammation (perforin deficiency and excess mature IL-18) by “clinical” measures, cytokine levels, flow cytometry, bulk RNA- and TCR-sequencing, and in functional studies.

Results: Flow cytometry analysis of dual susceptibility mice showed an expanded CD8 T-cells bearing high levels of the IL-18 receptor and multiple markers associated with exhaustion (PD-1, Lag-3, CD39), yet overproduce IFNg. Such “hyperinflammatory CD8 T-cells” are present in the reticuloendothelial organs (spleen, bone marrow, and liver) but not lymph nodes, peripheral blood, or thymus. Transcriptional analysis in splenic CD8 T-cells from dual susceptibility mice demonstrated that hyperactivated CD8 T cells reflect a pattern of activation distinct from acute effector, effector-memory, tissue-resident memory, or exhaustion when compared to well ascribed publicly available datasets. This analysis also revealed a strong signature for recent antigen activation. Bulk CD8 TCR sequencing showed dramatic oligoclonal hyper-expansion of TCR sequences from dual susceptibility mice as compared to controls with no significant clonal overlap between biologic replicate samples. Attempts to circumvent CD8 T-cell activation, using inducible deletion of Il18r1 only on CD8 T-cells, or by promoting allelic exclusion by fixing the T-cell receptor of DS mice, shows that hyperactivated CD8 T-cells can circumvent these efforts to hinder their ability to expand. In vitro, TCR stimulus is necessary for IL-18 to elicit its effects on yet does not inhibit activation- induced cell death.

Conclusion: IL-18 and cytotoxicity drive progressive and pathologic activation, post thymically, of a stochastic, oligoclonal CD8 T-cell population that underlies life-threatening immunopathology in HLH and MAS. Expansion of hyperactivated Cd8 T cells in reticuloendothelial organs curiously aligns with sites noted for high levels of hemophagocytosis. These data together suggest a requirement for TCR stimulation reminiscent of the infectious triggers common to HLH and MAS, demonstrate these cells remarkable resilience, and identify potentially-targetable nodes of T-cell activation.

Supporting image 1

Flow analysis of T cells from mice with single and double susceptibility factors to hyperinflammation.

Supporting image 2

Bubble Plot representing the TCRb clonality within mice with single and double susceptibility factors to hyperinflammation. The bigger the bubble the more expanded that specific clone is.

Supporting image 3

Dual susceptibility hyperactivated CD8 T cells circumvent the pressure of allelic exclusion (fixing the T-cell receptor).


Disclosures: E. Landy, None; S. Canna, Sobi, Ab2bio, Novartis, Immvention Therapeutics, sobi, Simcha Therapeutics; P. Tsoukas, None; V. Dang, None; J. Varghese, None.

To cite this abstract in AMA style:

Landy E, Canna S, Tsoukas P, Dang V, Varghese J. Cytokine Storm Susceptibility Factors IL-18 and Cytotoxic Impairment Converge on Pathologic CD8 T-cell Hyperactivation [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/cytokine-storm-susceptibility-factors-il-18-and-cytotoxic-impairment-converge-on-pathologic-cd8-t-cell-hyperactivation/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/cytokine-storm-susceptibility-factors-il-18-and-cytotoxic-impairment-converge-on-pathologic-cd8-t-cell-hyperactivation/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology